Wednesday, November 12, 12p-1p CST

About the Webinar: 

Learning Objectives: 

1. Identify why lung cancer is a leading cause of cancer death in the US and Nebraska.
2. Describe how low-dose CT scans can detect lung cancer early and save lives.
3. Discuss the criteria defining the population that can benefit the most from lung cancer screening.
4. Review resources NC2 can provide families, patients and providers regarding lung cancer screening.

About the Speaker

Joel Michalski, MD, PhD, is a member of the American Society of Hematology, American Society of Clinical Oncology and completed all his education at the University of Nebraska Medical Center. Dr. Michalski is a medical oncologist at Nebraska Cancer Specialists in Omaha. He has a strong interest in how the immune system interacts with cancer, and how those interactions can be utilized to treat many cancers. The fields of hematology and oncology are complex, and he is committed to providing the best, high quality care that modern medicine has to offer, along with a sincere desire to treat people, not just a disease. Dr. Michalski learned at an early age that hard work is the currency of success. He has applied that principle over many years of training and strives to provide that for every one of his patients.

Continuing Education

1.0 Continuing Education Contact Hours awarded by Iowa Western Community College, Iowa Board of Nursing Provider #6

NC2 webinars are included as a member benefit. Non-members will be charged $25/webinar OR can join as a member for $25/year to access all webinars.

Information for webinar will be included with your confirmation email and calendar invite.